290 related articles for article (PubMed ID: 18777740)
1. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
Lambiel J; Fumeaux T
Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
[No Abstract] [Full Text] [Related]
2. [Intensive glucose control in type 2 diabetes is beneficial].
Nilsson PM; Attvall S
Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
[No Abstract] [Full Text] [Related]
3. Intensive treatment of hyperglycaemia: ACCORD.
Klein R
Lancet; 2010 Aug; 376(9739):391-2. PubMed ID: 20594590
[No Abstract] [Full Text] [Related]
4. Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions.
Roussel R; Steg PG; Mohammedi K; Marre M; Potier L
Diabetes Obes Metab; 2018 Feb; 20(2):238-244. PubMed ID: 28597588
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
Meier M; Hummel M
Vasc Health Risk Manag; 2009; 5():859-71. PubMed ID: 19898642
[TBL] [Abstract][Full Text] [Related]
6. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
Laffin LJ; Bakris GL
Diabetes Obes Metab; 2018 Jun; 20(6):1335-1336. PubMed ID: 29424470
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control and CAD risk: a heretical thought.
Orchard TJ
Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
[No Abstract] [Full Text] [Related]
8. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
Füchtenbusch M; Hummel M
MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
[No Abstract] [Full Text] [Related]
9. Diabetic complications. The importance of glucose control.
Skyler JS
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):243-54. PubMed ID: 8799699
[TBL] [Abstract][Full Text] [Related]
10. [Near-norm blood sugar regulation in diabetes. Myocardial infarct rate halved].
MMW Fortschr Med; 2005 Sep; 147(35-36):4-5. PubMed ID: 16180560
[No Abstract] [Full Text] [Related]
11. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Riddle MC
Circulation; 2010 Aug; 122(8):844-6. PubMed ID: 20733112
[No Abstract] [Full Text] [Related]
12. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
Seufert J
Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
[No Abstract] [Full Text] [Related]
13. Fasting and post-prandial glucose and diabetic complication. A meta-analysis.
Monami M; Adalsteinsson JE; Desideri CM; Ragghianti B; Dicembrini I; Mannucci E
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):591-8. PubMed ID: 23711419
[TBL] [Abstract][Full Text] [Related]
14. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
Sjöholm A
Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia and cardiovascular risk in NIDDM.
Uusitupa MI; Niskanen LK
Diabetes Care; 1995 Jun; 18(6):884-5. PubMed ID: 7555522
[No Abstract] [Full Text] [Related]
16. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
[No Abstract] [Full Text] [Related]
17. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
Diabetes Care; 2009 Jan; 32(1):187-92. PubMed ID: 19092168
[No Abstract] [Full Text] [Related]
18. Diabetes. Paradoxical effects of tightly controlled blood sugar.
Taubes G
Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
[No Abstract] [Full Text] [Related]
19. Glucose control in type 2 diabetes: still worthwhile and worth pursuing.
Kahn SE
JAMA; 2009 Apr; 301(15):1590-2. PubMed ID: 19366780
[No Abstract] [Full Text] [Related]
20. Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
Wu H; Xu MJ; Zou DJ; Han QJ; Hu X
Chin Med J (Engl); 2010 Oct; 123(20):2908-13. PubMed ID: 21034605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]